ViewRay, Inc. financial data

Symbol
VRAYQ on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
2 Thermo Fisher Way, Oakwood Village, Ohio
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Mirax Corp (to 7/14/2015)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 207 % -43.9%
Quick Ratio 31.6 % -37.5%
Debt-to-equity 184 % +82.4%
Return On Assets -42.4 % -12.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 183 M shares +1.62%
Common Stock, Shares, Outstanding 183 M shares +1.63%
Entity Public Float 464 M USD -56.2%
Common Stock, Value, Issued 1.82 M USD +1.67%
Weighted Average Number of Shares Outstanding, Basic 182 M shares +1.43%
Weighted Average Number of Shares Outstanding, Diluted 182 M shares +1.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 106 M USD +44.1%
Research and Development Expense 33.2 M USD -0.06%
Selling and Marketing Expense 31.6 M USD +57.3%
General and Administrative Expense 51.2 M USD -3.87%
Operating Income (Loss) -109 M USD -2.66%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -110 M USD -1.23%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -110 M USD -1.23%
Earnings Per Share, Basic -0.61 USD/shares +4.69%
Earnings Per Share, Diluted -0.61 USD/shares +4.69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 81.3 M USD -54.9%
Accounts Receivable, after Allowance for Credit Loss, Current 47.5 M USD +69.7%
Inventory, Net 42.2 M USD +61.8%
Assets, Current 194 M USD -23.2%
Property, Plant and Equipment, Net 19 M USD -6.47%
Operating Lease, Right-of-Use Asset 5.4 M USD -40.5%
Other Assets, Noncurrent 10.9 M USD -9.32%
Assets 233 M USD -21.8%
Accounts Payable, Current 25.2 M USD +173%
Employee-related Liabilities, Current 12.6 M USD +62.7%
Accrued Liabilities, Current 20.8 M USD +12.7%
Contract with Customer, Liability, Current 23.9 M USD +72.6%
Liabilities, Current 167 M USD +109%
Contract with Customer, Liability, Noncurrent 2.4 M USD -68.1%
Operating Lease, Liability, Noncurrent 4.44 M USD -39.8%
Other Liabilities, Noncurrent 2.07 M USD -27%
Liabilities 178 M USD +18.1%
Retained Earnings (Accumulated Deficit) -873 M USD -14.5%
Stockholders' Equity Attributable to Parent 55.3 M USD -62.5%
Liabilities and Equity 233 M USD -21.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.6 M USD -65.5%
Net Cash Provided by (Used in) Financing Activities -2.19 M USD -41.2%
Net Cash Provided by (Used in) Investing Activities -1.18 M USD +3.37%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 183 M shares +1.63%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -57 M USD -62%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 85.5 M USD -53.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.09 M USD +156%
Deferred Tax Assets, Valuation Allowance 191 M USD +18.3%
Deferred Tax Assets, Gross 192 M USD +17.4%
Operating Lease, Liability 8.07 M USD -24.1%
Depreciation 1 M USD -16.7%
Payments to Acquire Property, Plant, and Equipment 1.18 M USD -3.37%
Lessee, Operating Lease, Liability, to be Paid 8.9 M USD -26.8%
Property, Plant and Equipment, Gross 57.7 M USD +5.08%
Operating Lease, Liability, Current 2.93 M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.3 M USD -1.67%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.36 M USD +2.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 835 K USD -45.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.1 M USD -36.5%
Deferred Tax Assets, Operating Loss Carryforwards 155 M USD +10.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 4 M USD +14.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 146 K USD -93%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.38 M USD -42.1%
Share-based Payment Arrangement, Expense 19.9 M USD -2.43%
Interest Expense 6.62 M USD +55.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%